Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Merck Announces FDA Approval Of Expanded Indication For EMEND
Merck Announces FDA Approval Of Expanded Indication For EMEND
Merck Announces FDA Approval Of Expanded Indication For EMEND
Submitted by
admin
on February 4, 2016 - 9:33am
Source:
NASDAQ.com
News Tags:
Merck
FDA
Emend
chemotherapy-induced nausea and vomiting
Headline:
Merck Announces FDA Approval Of Expanded Indication For EMEND
Do Not Allow Advertisers to Use My Personal information
